Claims
- 1. A compound of the formula ##STR14## wherein A is a sulfur atom or an SO, SO.sub.2, R--N.dbd.S, or R--N.dbd.SO group where R is a hydrogen atom or a benzoyl or phenylsulfonyl group, optionally substituted by a methyl group, or an acetyl or propionyl group;
- D is a linear or branched alkylene group having from 2 to 6 carbon atoms;
- R.sub.1 is an alkyl group having from 1 to 3 carbon atoms, optionally substituted by a phenyl group, or a phenyl group, each phenyl group being optionally substituted by an alkyl group having from 1 to 4 carbon atoms, a halogen atom, an alkoxy group having from 1 to 3 carbon atoms, a hydroxyl group, a cyclohexyl group, a phenyl group, an amino group, or an alkanoylamino group having from 1 to 3 carbon atoms; an alkyl group having from 4 to 8 carbon atoms; a cycloalkyl group having from 3 to 7 carbon atoms; a di-substituted or tri-substituted phenyl group of a mono-substituted or di-substituted hydroxyphenyl or aminophenyl group, the substituents, which may be the same or different, being selected from the group consisting of alkyl groups having from 1 to 4 carbon atoms, alkoxy groups having from 1 to 3 carbon atoms, and halogen atoms; a pyridyl-N-oxide group; or a 5-membered or 6-membered aromatic ring, optionally substituted by one or two alkyl groups each having from 1 to 3 carbon atoms, the aromatic ring containing from 1 to 3 nitrogen atoms or 1 nitrogen atom and 1 sulfur atom, while a phenyl group may optionally be fused onto the aromatic ring via two adjacent carbon atoms;
- R.sub.2 and R.sub.3, which may be identical or different, are each a hydrogen atom, phenyl group, alkyl group having from 1 to 6 carbon atoms, or cycloalkyl group having from 3 to 7 carbon atoms;
- R.sub.4 is a hydrogen atom or an alkyl group having from 1 to 3 carbon atoms;
- R.sub.5 is a hydrogen or halogen atom, a nitro group, or an alkyl group having from 1 to 3 carbon atoms; and
- R.sub.6 is a hydrogen or halogen atom or an alkyl group having from 1 to 3 carbon atoms.
- 2. A compound of claim 1, wherein
- A is as defined in claim 1;
- D is a linear alkylene group having from 2 to 6 carbon atoms;
- R.sub.1 is an alkyl group having from 1 to 8 carbon atoms; a cyclohexyl, benzyl, pyridyl, pyridyl-N-oxide, 2-benzothiazolyl, or 1,2,4-triazol-3-yl group; a 2-pyrimidinyl group optionally substituted by one or two methyl groups; a phenyl group optionally substituted by an alkyl group having from 1 to 4 carbon atoms, by a hydroxyl, methoxy, cyclohexyl, phenyl, or acetylamino group, or by a fluorine, chlorine, or bromine atom; a phenyl group di-substituted by chlorine or bromine atoms or by methyl or methoxy groups, where the substituents of the phenyl nucleus may be identical or different; or an aminophenyl or hydroxyphenyl group substituted by two alkyl groups, each having from 1 to 4 carbon atoms, or by two chlorine or bromine atoms;
- R.sub.2 and R.sub.3, which may be the same or different, are each a hydrogen atom, an alkyl group having from 1 to 6 carbon atoms, or a phenyl or cyclohexyl group;
- R.sub.4 is a hydrogen atom or a methyl group;
- R.sub.5 is a hydrogen, fluorine, chlorine, or bromine atom or a nitro, methyl, or ethyl group; and
- R.sub.6 is a hydrogen, chlorine, or bromine atom or a methyl or ethyl group.
- 3. A compound of claim 2 of the formula ##STR15## wherein A, D, R.sub.1 to R.sub.3, R.sub.5, and R.sub.6 are as defined in claim 2.
- 4. A compound of claim 3, wherein
- A is an SO, SO.sub.2, H--N.dbd.SO, CH.sub.3 CO--N.dbd.S, or CH.sub.3 --C.sub.6 H.sub.4 SO.sub.2 N.alpha.SO group;
- D is an n-butylene group;
- R.sub.1 is a phenyl group optionally substituted by a fluorine, chlorine, or bromine atom or a methyl, hydroxyl, methoxy, cyclohexyl, phenyl, or acetamino group; a phenyl group di-substituted by chlorine or bromine atoms or by methyl or methoxy groups, the substituents of the phenyl nucleus being the same or different; or a f4-amino-3,5-dibromophenyl, 3,5-di-tert.butyl-4-hydroxyphenyl, or pyridyl group;
- R.sub.2 and R.sub.3, which may be the same or different, each are a hydrogen atom or a methyl group;
- R.sub.5 is a hydrogen, chlorine, or bromine atom or a nitro or methyl group; and
- R.sub.6 is a hydrogen, chlorine, or bromine atom or a methyl group.
- 5. A compound of claim 3, wherein
- A is an SO, HN.dbd.SO, or CH.sub.3 CO--N.dbd.SO group;
- D is an n-butylene group;
- R.sub.1 is a phenyl group, optionally substituted in the 4-position by a fluorine, chlorine, or bromine atom or by a methyl, cyclohexyl, phenyl, hydroxyl, or methoxy group, or a 3-methoxyphenyl, 3,4-dichlorophenyl, 3,4-dimethoxyphenyl, 4-bromo-3-methyl-phenyl, 4-amino-3,5-dibromo-phenyl, or 4-hydroxy-3,5-di-tert.butyl-phenyl group;
- R.sub.2 and R.sub.3 are each a hydrogen atom or a methyl group;
- R.sub.5 is a hydrogen atom or, in the 7-position, a chlorine or bromine atom; and
- R.sub.6 is a hydrogen atom.
- 6. 6-[4-(4-Biphenylylsulfinyl)-butoxy]-4,4-dimethyl-4H-3,1-benzoxazin-2-one.
- 7. 6-[4-(4-Bromo-phenylsulfinyl)-butoxy]-4,4-dimethyl-4H-3,1-benzoxazin-2-one.
- 8. A pharmaceutical composition for the prophylaxis or treatment of thrombo-embolic diseases, for the treatment of arteriosclerosis, or for the prophylaxis of metastasis which consists essentially of one or more inert pharmaceutical carriers and/or diluents and an effective amount of a compound of claim 1.
- 9. A pharmaceutical composition for the prophylaxis or treatment of thrombo-embolic diseases, for the treatment of arteriosclerosis, or for the prophylaxis of metastasis which consists essentially of one or more inert pharmaceutical carriers and/or diluents and an effective amount of the compound of claim 6.
- 10. A pharmaceutical composition for the prophylaxis or treatment of thrombo-embolic diseases, for the treatment of arteriosclerosis, or for the prophylaxis of metastasis which consists essentially of one or more inert pharmaceutical carriers and/or diluents and an effective amount of the compound of claim 7.
- 11. A method for the prophylaxis or treatment of thrombo-embolic diseases, for the treatment of arteriosclerosis, or for the prophylaxis of metastasis in a warm-blooded animal or human in need of such treatment which comprises perorally, parenterally, or rectally administering to said animal or human an effective amount of a compound of claim 1.
- 12. A method for the prophylaxis or treatment of thrombo-embolic diseases, for the treatment of arteriosclerosis, or for the prophylaxis of metastasis in a warm-blooded animal or human in need of such treatment which comprises perorally, parenterally, or rectally administering to said animal or human an effective amount of the compound of claim 10.
- 13. A method for the prophylaxis or treatment of thrombo-embolic diseases, for the treatment of arteriosclerosis, or for the prophylaxis of metastasis in a warm-blooded animal or human in need of such treatment which comprises perorally, parenterally, or rectally administering to said animal or human an effective amount of the compound of claim 7.
Priority Claims (1)
Number |
Date |
Country |
Kind |
3217012 |
May 1982 |
DEX |
|
Parent Case Info
This application is a continuation of co-pending U.S. patent application Ser. No. 489,216, filed Apr. 27, 1983, abandoned.
US Referenced Citations (4)
Number |
Name |
Date |
Kind |
3526621 |
Bernardi et al. |
Sep 1970 |
|
3542774 |
Shavel et al. |
Nov 1970 |
|
4140789 |
Jaeggi et al. |
Feb 1979 |
|
4310527 |
Jaeggi et al. |
Jan 1982 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
489216 |
Apr 1983 |
|